Filter your results
- 2
- 2
- 2
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysisAnnals of Oncology, 2018, 29 (4), pp.803-811. ⟨10.1093/annonc/mdy035⟩
Journal articles
hal-02112951v1
|
||
|
Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trialsJournal of Thrombosis and Haemostasis, 2017, 15 (8), pp.1547-1558. ⟨10.1111/jth.13740⟩
Journal articles
hal-02112953v1
|